IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve
quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use of
intraoperative systemic lidocaine decrease postoperative opioid consumption and improve
quality of recovery after laparoscopic gastric bypass surgery.
This study has the potential to confirm an opioid sparing strategy for morbid obese patients
undergoing laparoscopic gastric bypass surgery. The high incidence of obstructive sleep apnea
and the increased risk of postoperative hypoxemia make the development of opioid sparing
techniques in this patient population warranted.